Together we will beat cancer

Donate

Ovarian cancer is the 6th most common cancer in women in the UK, with 7,400 people diagnosed each year. The symptoms of ovarian cancer can be very vague, particularly when the disease is in its early stages.

Ovarian cancer screening trial did not save lives

In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in.

Read More

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

Read More

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Read More

An existing blood test for ovarian cancer has been re-evaluated. The results are in

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

Read More

Are differences in treatment driving variation in ovarian cancer survival internationally?

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

Read More

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

Read More

The making of a living ovarian cancer biobank

Our scientists are growing a living ovarian cancer biobank in Manchester.

Read More

Research suggests statins could lower ovarian cancer risk

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

Read More

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

Read More

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

Read More